Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Zhonglin Hao"'
Autor:
Zhonglin Hao, Alberto Chiappori, Adam Schoenfeld, Paul Schwarzenberger, Jacob Sands, Lida Pacaud, Christopher delCorral, Dong Geng, Zhong Yun, Chaun Wang, Gianni Amato, Sahista Vahora
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/4560f577f2ab4103901046653b1ab56d
Autor:
Asha Nayak-Kapoor, Zhonglin Hao, Ramses Sadek, Robin Dobbins, Lisa Marshall, Nicholas N. Vahanian, W. Jay Ramsey, Eugene Kennedy, Mario R. Mautino, Charles J. Link, Ray S. Lin, Stephanie Royer-Joo, Xiaorong Liang, Laurent Salphati, Kari M. Morrissey, Sami Mahrus, Bruce McCall, Andrea Pirzkall, David H. Munn, John E. Janik, Samir N. Khleif
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-12 (2018)
Abstract Background Indoleamine-2,3-dioxygenase 1 (IDO1) catalyzes the oxidation of tryptophan into kynurenine and is partially responsible for acquired immune tolerance associated with cancer. The IDO1 small molecule inhibitor navoximod (GDC-0919, N
Externí odkaz:
https://doaj.org/article/fa3f41ad888d41f5a1c759f8b6fa21b2
Autor:
Jing Zhao, Yingfeng Xia, Joseph Kaminski, Zhonglin Hao, Frank Mott, Jeff Campbell, Ramses Sadek, Feng-Ming Spring Kong
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0157455 (2016)
Treatment related death (TRD) is the worst adverse event in chemotherapy and radiotherapy for patients with cancer, the reports for TRDs were sporadically. We aimed to study TRDs in non-small cell lung cancer (NSCLC) patients treated with concurrent
Externí odkaz:
https://doaj.org/article/ac545b6ac64445ca99069ee28aa9b609
Publikováno v:
BMJ Case Reports; Aug2024, Vol. 17 Issue 8, p1-4, 4p
Publikováno v:
The Oncologist.
This letter to the editor responds to the letter from Su et al, regarding concerns related to immortal time bias that may partially account for recently published study results.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62f21b327d515a256b32603a45a43251
https://doi.org/10.1093/oncolo/oyad133
https://doi.org/10.1093/oncolo/oyad133
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7db82127a3bcc1cc64c6021ce589c2f9
https://doi.org/10.7759/cureus.36547
https://doi.org/10.7759/cureus.36547
Autor:
Zhonglin Hao, Alexander Drilon, Everardus Otto Orlemans, Stephen V. Liu, Martin Gutierrez, Robin Guo, James M Hinson, Giuseppe Giaccone, Mark G. Kris, Christie Hilton
Publikováno v:
Lung Cancer
Objectives Single-agent heat shock protein 90 (HSP90) inhibition has demonstrated activity in oncogene-driven non-small cell and small cell lung cancers. SNX-5422 is an oral HSP90 inhibitor with increased activity in vitro with the addition of carbop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::383b67d0736c9e676a4d2ae2aa4c901c
https://doi.org/10.1016/j.lungcan.2021.10.001
https://doi.org/10.1016/j.lungcan.2021.10.001
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58c40cdd139e12b88a1caebe04b36754
https://doi.org/10.7759/cureus.29576
https://doi.org/10.7759/cureus.29576
Abstract CT221: Phase II of frontline maintenance rucaparib in combination with nivolumab in ES SCLC
Autor:
Aman Chauhan, Jill Kolesar, Donglin Yan, Zhonglin Hao, Ronald McGarry, John Villano, Ralph Zinner, Ashish Maskey, Jordan Miller, Timothy Mullett, Aman Khurana, Xitong Zhou, Garima Gupta, Daniel Flora, Colleen Darnell, Richard O'Neil, Charles Kunos, Mark B. Evers, Lowell Anthony, Susanne Arnold
Publikováno v:
Cancer Research. 83:CT221-CT221
Purpose: Immune checkpoint inhibitor (ICI) maintenance therapy is standard of care for frontline management of extensive stage small cell lung cancer (ES SCLC). However, overall survival benefit of addition of ICI maintenance to frontline ES SCLC tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35b8543b29f48a807c2575a354336de9
https://doi.org/10.1158/1538-7445.am2023-ct221
https://doi.org/10.1158/1538-7445.am2023-ct221
Publikováno v:
Third International Conference on Electronics and Communication; Network and Computer Technology (ECNCT 2021).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::233be934be10f181812bcbb37041621c
https://doi.org/10.1117/12.2629113
https://doi.org/10.1117/12.2629113